Cited by 121

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Parasitic helminth infections and the control of human allergic and autoimmune disorders

Maizels, R.M.·2016·Clinical Microbiology and Infection

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmi.2016.04.024

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 72

  1. Maizels, 2008, T-cell regulation in helminth parasite infections: implications for inflammatory diseases, Chem Immunol Allergy, 94, 112, 10.1159/000154944 · DOI
  2. Asher, 2006, Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC phases one and three repeat multicountry cross-sectional surveys, Lancet, 368, 733, 10.1016/S0140-6736(06)69283-0 · DOI · Paper page
  3. Gale, 2002, The rise of childhood type 1 diabetes in the 20th century, Diabetes, 51, 3353, 10.2337/diabetes.51.12.3353 · DOI
  4. Economou, 2008, New global map of Crohn's disease: genetic, environmental, and socioeconomic correlations, Inflamm Bowel Dis, 14, 709, 10.1002/ibd.20352 · DOI
  5. McKay, 2009, The therapeutic helminth?, Trends Parasitol, 25, 109, 10.1016/j.pt.2008.11.008 · DOI
  6. McSorley, 2012, Helminth infections and host immune regulation, Clin Micro Rev, 25, 585, 10.1128/CMR.05040-11 · DOI · Paper page
  7. Hotez, 2008, Helminth infections: the great neglected tropical diseases, J Clin Invest, 118, 1311, 10.1172/JCI34261 · DOI
  8. King, 2015, It's time to dispel the myth of ‘asymptomatic’ schistosomiasis, PLoS Negl Trop Dis, 9, e0003504, 10.1371/journal.pntd.0003504 · DOI
  9. Maizels, 2003, Regulation of the immune response by helminth parasites: cellular and molecular mechanisms, Nat Rev Immunol, 3, 733, 10.1038/nri1183 · DOI
  10. Colley, 1986, Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease, Am J Trop Med Hyg, 35, 793, 10.4269/ajtmh.1986.35.793 · DOI
  11. Sartono, 1995, Elevated cellular responses and interferon-γ release after long-term diethylcarbamazine treatment of patients with human lymphatic filariasis, J Infect Dis, 171, 1683, 10.1093/infdis/171.6.1683 · DOI
  12. Mahanty, 1996, High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis, J Infect Dis, 173, 769, 10.1093/infdis/173.3.769 · DOI · Paper page
  13. Babu, 2009, Filarial lymphedema is characterized by antigen-specific Th1 and Th17 proinflammatory responses and a lack of regulatory T cells, PLoS Negl Trop Dis, 3, e420, 10.1371/journal.pntd.0000420 · DOI
  14. Mbow, 2013, T-helper 17 cells are associated with pathology in human schistosomiasis, J Infect Dis, 207, 186, 10.1093/infdis/jis654 · DOI
  15. Kurniawan, 1993, Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis, J Immunol, 150, 3941, 10.4049/jimmunol.150.9.3941 · DOI
  16. Jeannin, 1998, IgE versus IgG4 production can be differentially regulated by IL-10, J Immunol, 160, 3555, 10.4049/jimmunol.160.7.3555 · DOI
  17. Watanabe, 2007, T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment, Am J Trop Med Hyg, 77, 676, 10.4269/ajtmh.2007.77.676 · DOI
  18. Wammes, 2012, Regulatory T cells in human lymphatic filariasis: stronger functional activity in microfilaremics, PLoS Negl Trop Dis, 6, e1655, 10.1371/journal.pntd.0001655 · DOI
  19. Metenou, 2013, Regulatory T cell subsets in filarial infection and their function, Front Immunol, 4, 305, 10.3389/fimmu.2013.00305 · DOI
  20. Sakaguchi, 2008, Regulatory T cells and immune tolerance, Cell, 133, 775, 10.1016/j.cell.2008.05.009 · DOI
  21. Maizels, 2011, Regulatory T cells in infection, Adv Immunol, 112, 73, 10.1016/B978-0-12-387827-4.00003-6 · DOI
  22. Correale, 2008, Helminth infections associated with multiple sclerosis induce regulatory B cells, Ann Neurol, 64, 187, 10.1002/ana.21438 · DOI
  23. Hussaarts, 2011, Regulatory B-cell induction by helminths: implications for allergic disease, J Allergy Clin Immunol, 128, 733, 10.1016/j.jaci.2011.05.012 · DOI · Paper page
  24. Labeaud, 2009, Do antenatal parasite infections devalue childhood vaccination?, PLoS Negl Trop Dis, 3, e442, 10.1371/journal.pntd.0000442 · DOI · Paper page
  25. Johnston, 2014, Helminths and immunological tolerance, Transplantation, 97, 127, 10.1097/TP.0b013e3182a53f59 · DOI
  26. Salgame, 2013, Effect of helminth-induced immunity on infections with microbial pathogens, Nat Immunol, 14, 1118, 10.1038/ni.2736 · DOI
  27. Wammes, 2010, Regulatory T cell in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum, Eur J Immunol, 40, 437, 10.1002/eji.200939699 · DOI
  28. Mishra, 2014, Systemic impact of intestinal helminth infections, Mucosal Immunol, 7, 753, 10.1038/mi.2014.23 · DOI
  29. Greenwood, 1968, Autoimmune disease and parasitic infections in Nigerians, Lancet, 2, 380, 10.1016/S0140-6736(68)90595-3 · DOI
  30. van den Biggelaar, 2000, Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10, Lancet, 356, 1723, 10.1016/S0140-6736(00)03206-2 · DOI
  31. van den Biggelaar, 2004, Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren, J Infect Dis, 189, 892, 10.1086/381767 · DOI · Paper page
  32. McKay, 2015, Not all parasites are protective, Parasite Immunol, 37, 324, 10.1111/pim.12160 · DOI
  33. Araujo, 2000, Inverse association between skin response to aeroallergen and Schistosoma mansoni infection, Int Arch Allergy Immunol, 123, 145, 10.1159/000024433 · DOI
  34. Cooper, 2003, Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics, J Allergy Clin Immunol, 111, 995, 10.1067/mai.2003.1348 · DOI
  35. Feary, 2011, Atopy and current intestinal parasite infection: a systematic review and meta-analysis, Allergy, 66, 569, 10.1111/j.1398-9995.2010.02512.x · DOI · Paper page
  36. Cooper, 2006, Human allergy and geohelminth infections: a review of the literature and a proposed conceptual model to guide the investigation of possible causal associations, Br Med Bull, 79–80, 203, 10.1093/bmb/ldl015 · DOI
  37. Smits, 2007, Protective effect of Schistosoma mansoni infection on allergic asthma depends on intensity and chronicity of infection, J Allergy Clin Immunol, 120, 932, 10.1016/j.jaci.2007.06.009 · DOI
  38. Flohr, 2010, Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam, Clin Exp Allergy, 40, 131, 10.1111/j.1365-2222.2009.03346.x · DOI · Paper page
  39. Mutapi, 2011, Schistosome infection intensity is inversely related to auto-reactive antibody levels, PLoS One, 6, e19149, 10.1371/journal.pone.0019149 · DOI
  40. Correale, 2007, Association between parasite infection and immune responses in multiple sclerosis, Ann Neurol, 61, 97, 10.1002/ana.21067 · DOI
  41. Correale, 2011, The impact of parasite infections on the course of multiple sclerosis, J Neuroimmunol, 233, 6, 10.1016/j.jneuroim.2011.01.002 · DOI · Paper page
  42. Broadhurst, 2010, IL-22+ CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient, Sci Transl Med, 2, 60ra88, 10.1126/scitranslmed.3001500 · DOI
  43. Weinstock, 2013, Translatability of helminth therapy in inflammatory bowel diseases, Int J Parasitol, 43, 245, 10.1016/j.ijpara.2012.10.016 · DOI · Paper page
  44. Fleming, 2015, Clinical trials of helminth therapy in autoimmune diseases: rationale and findings, Parasite Immunol, 37, 277, 10.1111/pim.12175 · DOI
  45. Summers, 2003, Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease, Am J Gastroenterol, 98, 2034, 10.1111/j.1572-0241.2003.07660.x · DOI
  46. Summers, 2005, Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial, Gastroenterology, 128, 825, 10.1053/j.gastro.2005.01.005 · DOI · Paper page
  47. Summers, 2005, Trichuris suis therapy in Crohn's disease, Gut, 54, 87, 10.1136/gut.2004.041749 · DOI · Paper page
  48. Garg, 2014, Helminth therapy (worms) for induction of remission in inflammatory bowel disease, Cochrane Database Syst Rev, 1, CD009400
  49. Bager, 2010, Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial, J Allergy Clin Immunol, 125, 123, 10.1016/j.jaci.2009.08.006 · DOI
  50. Bourke, 2012, Trichuris suis ova therapy for allergic rhinitis does not affect allergen-specific cytokine responses despite a parasite-specific cytokine response, Clin Exp Allergy, 42, 1582, 10.1111/j.1365-2222.2012.04063.x · DOI · Paper page
  51. Jouvin, 2012, Trichuris suis ova: testing a helminth-based therapy as an extension of the hygiene hypothesis, J Allergy Clin Immunol, 130, 3, 10.1016/j.jaci.2012.05.028 · DOI
  52. Benzel, 2012, Immune monitoring of Trichuris suis egg therapy in multiple sclerosis patients, J Helminthol, 86, 339, 10.1017/S0022149X11000460 · DOI
  53. Fleming, 2011, Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study, Mult Scler, 17, 743, 10.1177/1352458511398054 · DOI
  54. Voldsgaard, 2015, Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect, Mult Scler, 21, 1723, 10.1177/1352458514568173 · DOI
  55. Fleming, 2014, Clinical trial of helminth-induced immunomodulatory therapy (HINT 2) in relapsing-remitting multiple sclerosis, Neurology, 82, 149
  56. Feary, 2009, Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study, Clin Exp Allergy, 39, 1060, 10.1111/j.1365-2222.2009.03187.x · DOI
  57. Feary, 2010, Experimental hookworm infection: a randomized placebo-controlled trial in asthma, Clin Exp Allergy, 40, 299, 10.1111/j.1365-2222.2009.03433.x · DOI · Paper page
  58. Croese, 2006, A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors, Gut, 55, 136, 10.1136/gut.2005.079129 · DOI · Paper page
  59. Daveson, 2011, Effect of hookworm infection on wheat challenge in celiac disease—a randomised double-blinded placebo controlled trial, PLoS One, 6, e17366, 10.1371/journal.pone.0017366 · DOI · Paper page
  60. Evans, 2015, Worms as therapeutics for allergy: understanding why benefits in animal studies have not translated into clinical success, J Allergy Clin Immunol, 135, 343, 10.1016/j.jaci.2014.07.007 · DOI
  61. Helmby, 2015, Human helminth therapy to treat inflammatory disorders—where do we stand?, BMC Immunol, 16, 12, 10.1186/s12865-015-0074-3 · DOI · Paper page
  62. Leonardi, 2015, Helminth therapy for organic diseases?, Transl Res, 166, 586, 10.1016/j.trsl.2015.06.016 · DOI
  63. Finlay, 2014, Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases, Immunol Rev, 259, 206, 10.1111/imr.12164 · DOI
  64. Johnston, 2009, Parasitic helminths: a pharmacopeia of anti-inflammatory molecules, Parasitology, 136, 125, 10.1017/S0031182008005210 · DOI
  65. Heylen, 2014, Of worms, mice and man: an overview of experimental and clinical helminth-based therapy for inflammatory bowel disease, Pharmacol Ther, 143, 153, 10.1016/j.pharmthera.2014.02.011 · DOI
  66. Harnett, 2010, Helminth-derived immunomodulators: can understanding the worm produce the pill?, Nat Rev Immunol, 10, 278, 10.1038/nri2730 · DOI
  67. McSorley, 2013, Immunomodulation by helminth parasites: defining mechanisms and mediators, Int J Parasitol, 43, 301, 10.1016/j.ijpara.2012.11.011 · DOI
  68. Shepherd, 2015, Identifying the immunomodulatory components of helminths, Parasite Immunol, 37, 293, 10.1111/pim.12192 · DOI · Paper page
  69. Hewitson, 2009, Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity, Mol Biochem Parasitol, 167, 1, 10.1016/j.molbiopara.2009.04.008 · DOI
  70. Schnoeller, 2008, A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages, J Immunol, 180, 4265, 10.4049/jimmunol.180.6.4265 · DOI
  71. Harnett, 2010, The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease, Clin Exp Immunol, 159, 256, 10.1111/j.1365-2249.2009.04064.x · DOI
  72. Navarro, 2013, The hookworm pharmacopoeia for inflammatory diseases, Int J Parasitol, 43, 225, 10.1016/j.ijpara.2012.11.005 · DOI

Cited by

Sorted by citations

Metadata

Authors
Maizels, R. M.
Venue
Clinical Microbiology and Infection
Publisher
Elsevier BV
Published
2016-06
Volume
22
Issue
6
Pages
481-486
ISSN
1198-743X
Cited by
121
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review